CJ Launches Chronic Renal Failure Medication
Published: 2005-01-28 06:56:00
Updated: 2005-01-28 06:56:00
CJ Pharmaceutical Division announced this week that the company makes an official launching of chronic renal failure medication Kremezin in the domestic market starting February 1st, under the exclusive promotion contract withSankyoCo. Ltd.
According to the company, Kremezin, an oral absorben...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
